Overview
Why Beta-Blocker Choice Depends on the Indication
A beta blocker is not simply a medication that lowers the pulse.
A beta-blocker is not simply a medication that lowers the pulse. Its value depends on why adrenergic stimulation is harmful and whether the patient can tolerate slower rate, weaker contractility, and reduced AV-nodal conduction. The first prescribing question is therefore the indication: HFrEF, ischaemia, atrial fibrillation rate control, portal hypertension, thyrotoxicosis, or another specific use. The second is whether the patient is stable enough to receive it. A patient with chronic HFrEF who is euvolaemic and perfusing is very different from a patient with pulmonary oedema, shock, or escalating inotrope requirements. Agent selection then depends on receptor profile, formulation, organ clearance, interactions, and patient-specific risks such as asthma or hypoglycaemia unawareness. Beta-blockers are not interchangeable merely because they share a drug class.